PlantForm lands DARPA contract to develop nerve agent antidote

11/25/2012 | Guelph Mercury (Ontario), The

The U.S. Defense Advanced Research Projects Agency awarded PlantForm a contract worth $1.77 million to improve an enzyme that enhances protection against sarin gas and other nerve agents. "The prime application of this enzyme is in people who will be going into an area where the gas has been or might be released," president and CEO Don Stewart said. PlantForm will collaborate with Kentucky BioProcessing, Aragen Bioscience and Defence Research and Development Canada on the project.

View Full Article in:

Guelph Mercury (Ontario), The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY